Laura Gover, Andrew Anguko, Jane Bruce, Godfrey Magumba, et al.
1
Laurence Cibrelus
1
Ledikwe, J.H., Kejelepula, M., Maupo, K., et al.
1
Lena Morgon Banks and Sarah Polack
1
Lesotho National AIDS Commission, Government of Lesotho
1
Llyod, A.
1
Lucerne University
1
Lucinda Ramos
1
Lukito, A.A., A.U. Rahajoe, L.I. Rilantono, et al.,
1
M. Ballard, Bancroft E., Nesbit J., et al.
1
M. Beusenberg et al.
1
M. Doara, D. Choroliani, P. de Colombani
1
M. Doherty
1
M. F. Silveira
1
M. Gallardo, et al.
1
M. Ghidinelli
1
M. Holtmann
1
M. Joffres
1
M. Kan
1
M. Manova
1
M. Mansfeld
1
M. Penazzato
1
M. R. Jordan
1
M. Semrau
1
M. SHOWKAT GANI et al.
1
M. SHOWKAT GANI, MAL ABIKA SARKER, BULBUL ASHRAF SIDDIQI, ILIA S MAHMUD,YAMIN TAUSEEF JAHANGIR, SA LLY THEOBALD, HERMEN ORM EL, SALAUDDIN BISWAS , KUHEL FAIZUL ISLAM, SUBORN A CAMELLIA, SABINA F AIZ RASHID
1
M. Smelyanskaya, J. Duncan
1
M. Sundararaj
1
M. van den Boom
1
M.-R. B-Lajoie
1
M.Johnson
1
M.N. Ngongondo
1
MacQuarrie, Kerry L.D., Rebecca Winter, and Sunita Kishor
1
MacQuarrie, Kerry L.D., Sarah E.K. Bradley, Alison Gemmill, and Sarah Staveteig
1
Mairie de Paris
1
Makatjane, T. J., T. Hlabana, and E. M. Letete
1
Malaria Consortium
1
Malaria Journal
1
Malawi Ministry of Health (MOH), Save the Children
1
Management Sciences for Health
1
March of Dimes
1
Marie-Luise Abshagen, Anna Cavazzini, Laura Graen, Wolfgang Obenland
1
Mark F. Cotton
1
Mark W. Rosegrant | Jawoo Koo | Nicola Cenacchi
1
Mary De Silva, Lucy Lee& Grace Ryan
1
Mary-Anne Hartley, Alyssa Young, Anh-Minh Tran et al.
1
Marzouk M., Rayes D., Y. Douedari et al.
1
Massoda Tonye, S.G.
1
Maurice Bucagu, Jean M. Kagubare, Paulin Basinga, Fidèle Ngabo, Barbara K Timmons & Angela C Lee
1
McGahey, Christopher
1
MCNV, Global Initiative on Psychiatry, and World Granny
1
Measles Initiative
1
Medecins Sans Frontiers
1
Mediscript Ltd
1
Melanie Duncan, et al.
1
Mental, Neurological, and Substance Use Disorders: Disease Control Priorities, Third Edition (Volume 4).
1
Mèdecines sans Frontières MSF
1
Médecins Sans Frontières (MSF)
1
MHFA
1
mhGAP
1
Michael T. Osterholma, Kristine A. Moorea, Nicholas S. Kelley et al.
1
Mike Wessells
1
Miller, C.
1
Ministerio de sanidad - España
1
Ministère de la Santé et de l’Action Sociale et Ministère de la Justice
1
Ministry of Health
1
Ministry of Health & Child Welfare
1
Ministry of Health & Family Welfare, India, et al.
1
Ministry of Health and Family Welfare Government of the People's Republic of Bangladesh
1
Ministry of Health and Family Welfare, Directorate-General of Health Services, Mycobacterial Disease Control, National Tuberculosis Control Programme
1
Ministry of Health and Social Welfare, Central TB Division, India
1
Ministry of Health and Social Welfare, Government of India
1
Ministry of Health Ethiopia
1
Ministry of Health Ghana
1
Ministry of Health Uganda, NADIC, et al.
1
Ministry of Health, Ethiopia
1
Ministry of Health, Federal Democratic Republic of Ethiopia
1
Ministry of Health, Gabarone, Botswana
1
Ministry of Health, Ghana
1
Ministry of Health, Government of Kenya
1
Ministry of Health, Government of Liberia
1
Ministry of Health, Kenya
1
Ministry of Health, Liberia
1
Ministry of Health, Malawi
1
Ministry of Health, Pakistan
1
Ministry of Health, Republic of Kenya
1
Ministry of Health, Republic of Rwanda
1
Ministry of Health, Republic of South Africa
1
Ministry of Health, Rwanda
1
Ministry of Health, Rwanda & Rwanda Biomedical Centre
1
Ministry of Health, South Africa
1
Ministry of Health, Uganda
1
Ministry of Health, Zambia
1
Ministry of Public Health, Quatar
1
Missionalia
1
Mjelde, Marit
1
Mock, Charles N.
1
Mont, D.
1
MSF Access Campaign
1
MSMGF
1
Muller, Helgard et al.
1
Murphy, Ben
1
Myanmar Climate Change Alliance (MCCA)
1
Myanmar, Ministry of Health and Sports
1
N. Abera, T. Saballa, et al.
1
N. B. Ahmed
1
N. Bellare
1
N. C. Rollins
1
N. K. Arora
1
N. Mdaka
1
N. Reuge and D. Amaro
1
N.Dean
1
N.V. Salabai
1
NACO, Department of AIDS Control
1
NADMO Ghana
1
NASTAD Zambia
1
National Academy of Sciences of the USA
1
National Agency for Control of AIDS (NACA)
1
National Agency for the Control of AIDS (NACA), Government of Nigeria
1
National AIDS Commission (NAC)
1
National AIDS Commission of Liberia
1
National AIDS Control Organization (NACO), United Nations Development Programme (UNDP)
1
National AIDS Control Program
1
National HIV and AIDS Secretariat
1
National HIVAIDS Council Zambia
1
National Institute of Disaster Management (India)
1
National Institute of Disaster Management (NIDM), Deutsche Gesellschaft für Internationale Zusammenarbeit (GIZ)
1
National Institute of Health
1
National Malaria Elimination Centre, Ministry of Health, Zambia
1
National Malaria Elimination Programme Federal Ministry of Health National Population Commission, National Bureau of Statistics Federal Republic of Nigeria , et al.
1
National Polio Emergency Operations Centre (EOC), Islamabad, Pakistan
1
National Primary Health Care Development Agency
1
National TB Control Programme, Bangladesh
1
National Tuberculosis Leprosy and Lung Disease Program (NTLD-program), Ministry of Health, Republic of Kenya
1
ndia State-Level Disease Burden Initiative Cancer Collaborators
1
Neil M Ferguson, Daniel Laydon, Gemma Nedjati-Gilani, Natsuko Imai, Kylie Ainslie, Marc Baguelin, Sangeeta Bhatia, Adhiratha Boonyasiri, Zulma Cucunubá, Gina Cuomo-Dannenburg, Amy Dighe, Ilaria Dorigatti, Han Fu, Katy Gaythorpe, Will Green, Arran Hamlet, Wes Hinsley, Lucy C Okell, Sabine van Elsland, Hayley Thompson, Robert Verity, Erik Volz, Haowei Wang, Yuanrong Wang, Patrick GT Walker, Caroline Walters, Peter Winskill, Charles Whittaker, Christl A Donnelly, Steven Riley, Azra C Ghani.
1
Nepal Journal of Obstetrics and Gynaecology (NJOG)
1
Nepal Ministry of Health and Population, New ERA, and ICF International
1
Nesheim, Ingrid
1
Net Hope
1
Niederberger, E.
1
Norsk institutt for vannforskning (NIVA)
1
Norwegian Refugee Council, Internal Displacement Monitoring Centre
1
NSW Health and University of Western Sydney
1
Nugent, Rachel
1
Nugroho
1
Nunn, Marc
1
O. Drouin
1
O. Samoylova
1
O.M. Balakireva
1
Observatorio Regional de Recursos Humanos de Salud
1
Office for the Coordination of Humanitarian Affairs OCHA
1
ohns Hopkins Center for Communication Programs
1
Olney, Jack J.
1
ONUSIDA
1
OpenLearn Create
1
Organización Mundial de la Salud (Américas)
1
Organización Mundial de la Salud OMS
1
OSF and OSISA the Centre for Human RightsPretoria University Law Press (PULP)
Technical Note on Antimicrobial Resistance
This document reflects UNICEF’s response to the growing global threat of AMR to child survival, growth and development. It identifies UNICEF’s AMR-specific and AMR-sensitive actions in reducing infections, promoting access to and optimal use of antimic...robials, and increasing AMR awareness and understanding. Of particular relevance to this group, UNICEF country offices are directed to provide technical support for development and implementation of national AMR action plans, linking them as appropriate to maternal, newborn and child health programmes and ensuring these are prioritized in both surveillance and policy changes. The guidance note on AMR is intended to inform UNICEF’s AMR-related internal initiatives, programming and activities, as well as external engagements with governments and other stakeholders.more
2nd Generation HIV Surveillance in Pakistan, Round 5
The Overall objective of this mapping study was to update population size estimates of selected key populations (PWID, FSWs, MSM & TGs) to create evidence for developing action plans for HIV prevention interventions in Pakistan. A total numbe...r of 23 cities/towns were selected for Mapping. This included 13 cities in Punjab province, 6 in Sindh Province and 2 cities each in KPK and Baluchistan provinces. large file: 70,5 MB The preview/download includes only the pages 1 to 23.more
The International Pharmaceutical Federation (FIP) is a global federation of national associations of pharmacists and
pharmaceutical scientists. In order to support these associations in their fight against AMR, FIP has prepared this
briefing document. It is an overview of the different activities ...that community and hospital pharmacists are involved
into prevent AMR and to reverse AMR rates.more
The most significant finding of the case study for integrating antimicrobial resistance (AMR)into existing programs and mobilising resources for funding in Nigeria, is that most of the AMR activities within the Nigerian National Action Plan (NAP)canalready be incorporated within exi...sting programs of the Federal Ministry of Health (FMOH), Federal Ministry of Agriculture and Rural Development (FMARD) and their agencies or institutes. Certain programs and initiatives already have an AMR element incorporated or could,with little effort,include some additional AMR actions, however much is already being planned and has started with existing federal funding and existing staffing and other resources including development partner support and is being driven by significant political will from the ministries as well as implementation support from the Nigerian Centers for Disease Control as the focal point.more
The Millennium Development Goals (MDGs) showed
that global commitment and collective action
could significantly reduce the disease burdens of
three deadly communicable diseases: HIV/AIDS,
tuberculosis (TB) and malaria. The MDGs helped
focus efforts on these three deadly diseases
and leveraged ...disease-specific programmes and
financing, thus achieving significant progress.more
This fourth progress report November 2020 of the Global HIV Prevention Coalition reviews the progress in the 28 focus countries and complements the three previous progress reports. This report describes key developments in 2019–2020, identifies challenges and opportunities (including those associa...ted with the COVID-19 pandemic) and outlines priorities for the years ahead. It is divided into two main sections.more
The growing understanding of how sequence information can contribute to improved public health is driving global investments in sequencing facilities and programmes. The falling cost and complexity of generating GSD provides opportunities for expanding sequencing capacity; however, challenges to wid...espread implementation remain. This document provides policy-makers and stakeholders with guidance on how to maximize the public health benefit of SARS-CoV-2 genomic sequencing activities in the short and long term as the pandemic continues to unfold. Practical considerations for the implementation of a virus genomic sequencing programme and an overview of the public health objectives of genomic sequencing are covered. This guidance focuses on SARS-CoV-2 but is applicable to other pathogens of public health concern.more
Summary of the main report: Direct and indirect effects of COVID-19 pandemic and response in South Asia .
It uses a series of exercises based on actual observed changes in services and intervention coverage to model impacts on mortality, hospitalizations, and ICU admissions due to COVID-19. It a...lso models the impact of nationwide stay-at-home orders to curb the spread of COVID-19 on maternal and child mortality, educational attainment of children, and the region’s economy. The study focuses on South Asia’s six most populous countries: Afghanistan, Bangladesh, Nepal, India, Pakistan and Sri Lanka and makes the case for interventions and strategies to minimise these indirect consequences.more
At a time when the world is reeling from the deepest global disruption and health crisis of a lifetime, this year’s Living Planet
report provides unequivocal and alarming evidence that nature is unraveling and that our planet is flashing red warning signs of
vital natural systems failure. The ...Living Planet Report 2020 clearly outlines how humanity’s increasing destruction of nature is having
catastrophic impacts not only on wildlife populations but also on human health and all aspects of our lives.more
The WHO End TB Strategy aims to end the global TB epidemic by 2030, in alignment with Goal 3 of the United Nations (UN) Sustainable Development Goals (SDGs). Member States of the World Health Organization (WHO) and the UN committed to ending the TB epidemic through adoption of WHO’s End TB Strateg...y and the UN SDGs in 2014 and 2015, respectivel
Almost half of the deaths worldwide caused by TB in 2019 occurred in the WHO South-East Asia Region, home to around a quarter of the global population. Maintaining robust progress in this Region is therefore essential if the global goal of ending the TB epidemic is to be realized. Despite substantial gains made in the Region, the threat to
health worldwide posed by the COVID-19 pandemic has the potential to reverse these gains and eclipse the focus on the global TB emergency.
While continuing to tackle COVID-19-related challenges, countries will need to rapidly and urgently deploy supplementary measures to address the large numbers of missed cases, poor treatment outcomes and, potentially, a higher TB burden.
The Regional Strategic Plan towards Ending TB in the Region 2021–2025 clearly articulates priority interventions, analyses the challenges, bottlenecks and opportunities, and focuses on implementation considerations in the Region.more
Infectious diseases continue to impose unpredictable burdens on global health and economies, a subject that requires constant research and updates. In this sense, the objective of the present article was to review studies on the role of wild animals as reservoirs and/or dispersers of etiological age...nts of human infectious diseases in order to compile data on the main wild animals and etiological agents involved in zoonotic outbreaks.more
Over the ages, human societies have altered local ecosystems and modified regional climates. Today the human influence has attained a global scale. This reflects the recent rapid increase in population size, energy consumption, intensity of land use, international trade and travel, and other human a...ctivities. These global changes have heightened awareness that the long-term good health of populations depends on the continued stability of biosphere's ecological, physical and socioeconomic systems.
The world's climate system is an integral part of the complex of life-supporting processes. Like other large systems, the global climate system is coming under pressure from human activities.
This book seeks to describe the context and process of global climate change, its actual or likely impacts on health, and how human societies and their governments should respond with particular focus on the health sector.more
Minimizing risk of developing antibiotic resistance and aquatic ecotoxicity in the environment resulting from the manufacturing of human antibiotic.
The Standard, facilitated by BSI Standards Limited (BSI), provides clear guidance to manufacturers in the global antibiotic supply chain to ensure t...hat their antibiotics are made responsibly, helping to minimize the risk of AMR in the environment.more
This report provides an overview of air pollution levels and associated health impacts in cities around the world. Since urban areas are often hotspots for poor air quality, city-level data can help to inform targeted efforts to curb urban air pollution and improve public health. This report draws o...n data from the Global Burden of Disease project and from peer-reviewed analyses led by Susan Anenberg of the George Washington University.more
Since 1996, trachoma has been targeted for elimination as a public health problem worldwide. The active trachoma criterion for national elimination as a public health problem is a TF1–9 < 5%, sustained for at least two years in the absence of antibiotic mass drug administration (MDA), in each form...erly endemic EU. Using A, F and E, health ministries and their partners have made considerable progress towards achieving this criterion in formerly endemic EUs worldwide. In 2002, an estimated 1517 million people lived in EUs in which EU-wide implementation of the A, F and E components of SAFE were thought to be needed for the purposes of global elimination of trachoma as a public health problem; by June 2021, that number had fallen to 136.2 million, a 91% reduction. Approximately 85% of the 136.2 million people living in EUs needing A, F and E in June 2021 were in WHO’s African Region.more
The following technical report outlines the rationale, process and results of a joint research study, coordinated by the World Health Organization (WHO) and the Pan-American Health Organization (PAHO), co-chaired by the Ministry of Health and Social Protection and the Ministry of Environment and Sus...tainable Development in collaboration with the Climate and Climate Air Coalition, the Stockholm Environment Institute, the Clean Air Institute and leading international and national experts. A rationale section describes the links between greenhouse gas (GHG) emissions, short-lived climate pollutants, air pollution and adverse health outcomes. A summary of the research study describes how scenarios were modelled to examine the health and economic implications of raising ambition in Colombia’s Nationally Determined Contribution (NDC) to the United Nations Framework Convention on Climate Change (UNFCCC)more
The African Regional Convening of the Global Initiative to Support Parents (GISP) stimulated the interest or engagement of almost 1500 individuals from 742 unique organizations in the fields of health, education, social welfare, women’s affairs, early childhood, water and sanitation, mental health..., violence prevention, innovative finance, climate, and many others. The convening united representatives across governments, civil society organizations, programme implementers, philanthropies, multilateral organizations, bilateral funders, private companies, universities, schools and day care centres, and hospitals around the common cause of supporting parents and caregivers.more
Cardiovascular disease (CVD) is the leading cause of global deaths, with the majority occurring in low- and middle-income countries (LMIC). The primary and secondary prevention of CVD is suboptimal throughout the world, but the evidence-practice gaps are much more pronounced in LMIC. Barriers at the... patient, health-care provider, and health system level prevent the implementation of optimal primary and secondary prevention. Identification of the particular barriers that exist in resource-constrained settings is necessary to inform effective strategies to reduce the identified evidence-practice gaps. Furthermore, targeting modifiable factors that contribute most significantly to the global burden of CVD, including tobacco use, hypertension, and secondary prevention for CVD will lead to the biggest gains in mortality reduction. We review a select number of novel, resource-efficient strategies to reduce premature mortality from CVD, including: (1) effective measures for tobacco control; (2) implementation of simplified screening and management algorithms for those with or at risk of CVD, (3) increasing the availability and affordability of simplified and cost-effective treatment regimens including combination CVD preventive drug therapy, and (4) simplified delivery of health care through task-sharing (non-physician health workers) and optimizing self-management (treatment supporters). Developing and deploying systems of care that address barriers related to the above, will lead to substantial reductions in CVD and related mortality.more